Crude Heparin Market

Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.

Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines.

Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of Crude Heparin Market is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.

Crude Heparin Market contains market size and forecasts of Crude Heparin in global, including the following market information:

• Global Crude Heparin Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Crude Heparin Market Sales, 2017-2022, 2023-2028, (MT)
• Global top five Crude Heparin companies in 2021 (%)

The global Crude Heparin market was valued at 4011.5 million in 2021 and is projected to reach US$ 7065 million by 2028, at a CAGR of 8.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pig Intestine Mucosa Heparin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Crude Heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong and Hepac (Darling Ingredients), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Crude Heparin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Crude Heparin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Crude Heparin Market Segment Percentages, by Type, 2021 (%)

• Pig Intestine Mucosa Heparin
• Bovine Heparin and Others

Global Crude Heparin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Crude Heparin Market Segment Percentages, by Application, 2021 (%)

• Unfractionated Heparin (UFH)
• Low-Molecular-Weight Heparin (LMWH)

Global Crude Heparin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Crude Heparin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Crude Heparin revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Crude Heparin revenues share in global market, 2021 (%)
• Key companies Crude Heparin sales in global market, 2017-2022 (Estimated), (MT)
• Key companies Crude Heparin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bioiberica
• Shenzhen Hepalink
• Sanofi
• Nanjing King-friend
• Fengrun Biological Technology
• Aspen Oss
• Hebei Changshan Biochemical
• Changzhou Qianhong
• Hepac (Darling Ingredients)
• Huaian MDC Pharmaceutical
• Yantai Dongcheng Biochemicals